Briefing
Longitudinal circulating tumor DNA monitoring for detection of molecular residual disease in patients with penile squamous cell carcinoma.
Assays were designed for all 7 patients, and ctDNA was detectable at least once in all. Rising ctDNA prompted imaging that showed progression in 3 patients. Two of 7 remained alive with sustained clearance and 3 with persistent positivity had died at the time of the report.
- n: 7 patients with advanced HPV-unassociated penile squamous cell carcinoma; single-center retrospective
- Assay: Signatera (personalized tumor-informed)